PEP Stock Analysis: PepsiCo | NASDAQ
Beverages - Non-Alcoholic | NASDAQ, USA | Market Cap: 175.312m USD | 12M Return: -9.4% | US7134481081 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.26B
EPS Trend: 84.4%
Qual. Beats: 1
Rev. Trend: 86.8%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
PepsiCo, Inc. is a global manufacturer, marketer, distributor, and seller of convenient foods and beverages, operating through six reportable segments: PepsiCo Foods North America, PepsiCo Beverages North America, International Beverages Franchise, Europe Middle East and Africa, Latin America Foods, and Asia Pacific Foods. Its product portfolio spans cereals, chips, dips, granola bars, oatmeal, pasta, rice, syrups and mixes, refrigerated spreads, beverage concentrates, fountain syrups, ready-to-drink tea and coffee, as well as SodaStream sparkling water makers and dairy products marketed under regional brands such as Agusha, Chudo, and Domik v Derevne.
The company distributes its products through a multi-channel network that combines direct-store-delivery, customer warehouse, and third-party distributor systems, reaching wholesale distributors, foodservice operators, grocery, drug, convenience, discount/dollar, mass merchandisers, membership stores, hard discounters, authorized independent bottlers, and e-commerce retailers.
As a large-cap Consumer Staples issuer classified within the Soft Drinks & Non-alcoholic Beverages sub-industry, PepsiCo benefits from the defensive characteristics typical of the sector, including relatively stable demand and pricing power tied to recognized brand portfolios. The company was founded in 1898 and is headquartered in Purchase, New York.
- GLP-1 drug adoption pressures snack and beverage volumes
- Frito-Lay pricing power sustains North America Foods margins
- International emerging markets drive volume and revenue growth
| Net Income: 10.9b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 4.93 > 1.0 |
| NWC/Revenue: -2.01% < 20% (prev -2.86%; Δ 0.85% < -1%) |
| CFO/TA 0.13 > 3% & CFO 14.6b > Net Income 10.9b |
| Net Debt (41.4b) to EBITDA (17.9b): 2.31 < 3 |
| Current Ratio: 0.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.37b) vs 12m ago -0.36% < -2% |
| Gross Margin: 54.17% > 18% (prev 53.79%; Δ 0.38% > 0.5%) |
| Asset Turnover: 89.91% > 50% (prev 91.19%; Δ -1.28% > 0%) |
| Interest Coverage Ratio: 12.41 > 6 (EBIT TTM 13.5b / Interest Expense TTM 1.09b) |
| A: -0.02 (Total Current Assets 32.6b - Total Current Liabilities 34.5b) / Total Assets 112b |
| B: 0.67 (Retained Earnings 75.1b / Total Assets 112b) |
| C: 0.12 (EBIT TTM 13.5b / Avg Total Assets 109b) |
| D: 0.25 (Book Value of Equity 22.3b / Total Liabilities 89.5b) |
| Altman-Z'' = 3.16 = A |
| DSRI: 1.07 (Receivables 13.6b/12.6b, Revenue 98.2b/97.2b) |
| GMI: 0.99 (GM 53.79% / 54.17%) |
| AQI: 0.97 (AQ_t 0.44 / AQ_t-1 0.46) |
| SGI: 1.01 (Revenue 98.2b / 97.2b) |
| TATA: -0.03 (NI 10.9b - CFO 14.6b) / TA 112b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of October 11, 2026, the stock is trading at USD 125.97 with a total of 9,853,204 shares traded. Over the past week, the price has changed by +0.06%, over one month by -7.84%, over three months by -7.65% and over the past year by -9.42%.
Current recommended Stop Loss: 122.70 (which is 2.6% or 1.3 ATR below the current price).
PepsiCo has received a consensus analysts rating of 3.25. Therefore, it is recommended to hold PEP.
- StrongBuy: 3
- Buy: 2
- Hold: 18
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 148.6 | 18% |
P/E Trailing = 16.225
P/E Forward = 14.8588
P/S = 1.8091
P/B = 8.2976
P/EG = 1.376
Revenue TTM = 98.2b USD
EBIT TTM = 13.5b USD
EBITDA TTM = 17.9b USD
Long Term Debt = 42.3b USD (from longTermDebt, last fiscal year)
Short Term Debt = 9.22b USD (from shortTermDebt, last quarter)
Debt = 52.6b USD (from shortLongTermDebtTotal, last quarter) + Leases 719.0m
Net Debt = 41.4b USD (calculated: Debt 52.6b - CCE 11.2b)
Enterprise Value = 217b USD (175b + Debt 52.6b - CCE 11.2b)
Interest Coverage Ratio = 12.41 (Ebit TTM 13.5b / Interest Expense TTM 1.09b)
EV/FCF = 17.13x (Enterprise Value 217b / FCF TTM 12.7b)
FCF Yield = 5.84% (FCF TTM 12.7b / Enterprise Value 217b)
FCF Margin = 12.88% (FCF TTM 12.7b / Revenue TTM 98.2b)
Net Margin = 11.13% (Net Income TTM 10.9b / Revenue TTM 98.2b)
Gross Margin = 54.17% ((Revenue TTM 98.2b - Cost of Revenue TTM 45.0b) / Revenue TTM)
Gross Margin QoQ = 54.42% (prev 54.22%)
Tobins Q-Ratio = 1.94 (Enterprise Value 217b / Total Assets 112b)
Interest Expense / Debt = 2.07% (Interest Expense 1.09b / Debt 52.6b)
Taxrate = 20.10% (2.76b / 13.7b)
NOPAT = 10.8b (EBIT 13.5b * (1 - 20.10%))
Current Ratio = 0.94 (Total Current Assets 32.6b / Total Current Liabilities 34.5b)
Debt / Equity = 2.36 (Debt 52.6b / totalStockholderEquity, last quarter 22.3b)
Debt / EBITDA = 2.31 (Net Debt 41.4b / EBITDA 17.9b)
Debt / FCF = 3.27 (Net Debt 41.4b / FCF TTM 12.7b)
Total Stockholder Equity = 21.5b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.00% (Net Income 10.9b / Total Assets 112b)
RoE = 50.73% (Net Income TTM 10.9b / Total Stockholder Equity 21.5b)
RoCE = 21.16% (EBIT 13.5b / Capital Employed (Equity 21.5b + L.T.Debt 42.3b))
RoIC = 13.21% (NOPAT 10.8b / Invested Capital 81.8b)
WACC = 4.42% (E(175b)/V(228b) * Re(5.25%) + D(52.6b)/V(228b) * Rd(2.07%) * (1-Tc(0.20)))
Discount Rate = 5.25% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.16 | Cagr: -0.39%
[DCF] Terminal Value 77.97% ; FCFF base≈10.3b ; Y1≈11.8b ; Y5≈17.4b
[DCF] Fair Price = 161.2 (EV 262b - Net Debt 41.4b = Equity 220b / Shares 1.37b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 84.40 | EPS CAGR: 2.94% | SUE: 1.57 | # QB: 1
Revenue Correlation: 86.80 | Revenue CAGR: 2.90% | SUE: 0.18 | # QB: 0
EPS current Year (2026-12-31): EPS=8.55 | Chg30d=-0.11% | Revisions=-40% | GrowthEPS=+5.0% | GrowthRev=+5.3%
EPS next Year (2027-12-31): EPS=8.91 | Chg30d=-0.73% | Revisions=-50% | GrowthEPS=+4.2% | GrowthRev=+2.8%
[Analyst] Revisions Ratio: -62% (up=0, down=5)